Phase 1 clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{3ea930713c7d409fa1e270606b5a622c,

title = "Phase 1 clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel",

author = "\{Meerum Terwogt\}, J.M. and \{ten Bokkel Huinink\}, W.W. and J.H.M. Schellens and H. Rosing and J.H. Beijnen",

year = "2001",

language = "Undefined/Unknown",

volume = "12",

pages = "315--325",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Phase 1 clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel

AU - Meerum Terwogt, J.M.

AU - ten Bokkel Huinink, W.W.

AU - Schellens, J.H.M.

AU - Rosing, H.

AU - Beijnen, J.H.

PY - 2001

Y1 - 2001

M3 - Article

SN - 0959-4973

VL - 12

SP - 315

EP - 325

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

ER -